Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06403852 · ClinicalTrials.gov registry record · Phase 2
Investigating Near-Threshold Perception During Anesthetic Sedation
A Phase 2 study of Anesthesia and fMRI, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06403852 is a Phase 2 study of Anesthesia and fMRI that has completed, run by University of Michigan. The registered enrollment target is 36 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06403852, a Phase 2 study of Anesthesia and fMRI, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers expect to gain a deeper understanding of mental function during different levels of anesthesia, and to evaluate if the use of ultrasonic brain stimulation accelerates return to consciousness. Propofol is FDA approved for use in patients undergoing an anesthetic for medical treatment but is not approved for use in healthy volunteers.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Functional Magnetic Resonance Imaging (fMRI) with propofol
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2025-10-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06403852
The ClinicalTrials.gov registry entry for NCT06403852 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Functional Magnetic Resonance Imaging (fMRI) with propofol is the first listed.
NCT06403852 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06403852 about?
NCT06403852 is a clinical study titled "Investigating Near-Threshold Perception During Anesthetic Sedation". The researchers expect to gain a deeper understanding of mental function during different levels of anesthesia, and to evaluate if the use of ultrasonic brain stimulation accelerates return to consciousness. Propofol is FDA approved for use in patients undergoing an anesthetic for medical treatment...
What is the current status of trial NCT06403852?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2024-05-10. Estimated completion is 2025-10-03.
What conditions does trial NCT06403852 study?
This clinical trial studies the following conditions: Anesthesia, fMRI, Propofol.
What interventions are being tested in trial NCT06403852?
The interventions under investigation include: Functional Magnetic Resonance Imaging (fMRI) with propofol (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06403852?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06403852 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects
COMPLETED · Phase 2
-
Dose-Escalation Safety and Pharmacokinetic Study of K305
COMPLETED · Phase 2
-
EEG Studies of Ketamine General Anesthesia
COMPLETED · Phase 2
-
Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age
COMPLETED · Phase 2
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.